Catalyst Wire Dossier Catalyst Wire Dossier

Netakimab

netakimab · Biocad
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Netakimab, covering 2025-06-24 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Efficacy and Safety of Netakimab in Chinese Patients With Moderate to Severe Plaque Psoriasis [Phase 3]

See pricing